ABIOMED Announces Notice of Inclusion in Russell 2000 Investment Index.Business Editors and Health/Medical Writers DANVERS, Mass.--(BW HealthWire)--July 14, 2000 ABIOMED, Inc. (pronounced "AB-EE-O-MED"), (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ABMD ABMD areal bone mineral density ABMD AEGIS Ballistic Missile Defense (US Navy) ABMD Advanced Ballistic Missile Defense ) has announced that, effective July 2000, trading in shares of ABIOMED's common stock are included in the Russell 2000 investment index. The Russell 2000 Index Russell 2000 Index An index measuring the performance of the 2,000 smallest companies in the Russell 3000 Index, which is made up of 3,000 of the biggest U.S. stocks. The Russell 2000 serves as a benchmark for small-cap stocks in the United States. is compiled, maintained and produced by the Frank Russell Company of Tacoma, Washington. The Index, used to measure stock price performance, tracks changes in market capitalization Market Capitalization A measure of a public company's size. Market capitalization is the total dollar value of all outstanding shares. It's calculated by multiplying the number of shares times the current market price. This term is often referred to as market cap. of two thousand U.S. companies. John F. Thero, ABIOMED's Chief Financial Officer said, "ABIOMED's inclusion in the Russell 2000 reflects ABIOMED's growth and increasing market presence. We look forward to the added visibility that inclusion in this index can bring." Based in Danvers, Massachusetts, ABIOMED, Inc. develops, manufactures and markets innovative cardiovascular products and is a leader in the research and development of advanced heart assist and replacement systems. The Company's BVS BVS Biblioteca Virtual em Saúde (Brazil) BVS Bureau of Vital Statistics BVS Brethren Volunteer Service (Church of the Brethren) BVS Boston Vegetarian Society (Cambridge, MA) 5000(TM) is the most widely used FDA-approved cardiac assist device for all patients with reversible heart failure. The Company's AbioCor(TM) Implantable Replacement Heart is in an advanced stage of development and intended to extend the lives of patients who would otherwise die from heart failure. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion